LIQUISPHERE

Serial Number 87929599
606

Registration Progress

Application Filed
May 21, 2018
Under Examination
Dec 18, 2018
Approved for Publication
Oct 23, 2018
Published for Opposition
Oct 23, 2018
Registered

Basic Information

Serial Number
87929599
Filing Date
May 21, 2018
Published for Opposition
October 23, 2018
Abandonment Date
January 24, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 24, 2022
Classes
005

Rights Holder

Contract Pharmacal Corp.

03
Address
135 Adams Ave.
Hauppauge, NY 11788

Ownership History

Contract Pharmacal Corp.

Original Applicant
03
Hauppauge, NY

Contract Pharmacal Corp.

Owner at Publication
03
Hauppauge, NY

Legal Representation

Attorney
Dana S. Gross

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description
Jan 24, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jan 24, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 14, 2021 DOCK D ASSIGNED TO EXAMINER
Jun 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 15, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 15, 2021 EX5G S SOU EXTENSION 5 GRANTED
Jun 8, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 8, 2021 EXT5 S SOU EXTENSION 5 FILED
May 26, 2021 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 19, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 17, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 17, 2020 EXT4 S SOU EXTENSION 4 FILED
Dec 17, 2020 EX4G S SOU EXTENSION 4 GRANTED
May 28, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 26, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
May 26, 2020 EXT3 S SOU EXTENSION 3 FILED
May 26, 2020 EX3G S SOU EXTENSION 3 GRANTED
Dec 18, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 16, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 16, 2019 EXT2 S SOU EXTENSION 2 FILED
Dec 16, 2019 EX2G S SOU EXTENSION 2 GRANTED
Jun 7, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 5, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 5, 2019 EXT1 S SOU EXTENSION 1 FILED
Jun 5, 2019 EX1G S SOU EXTENSION 1 GRANTED
Dec 18, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 23, 2018 PUBO A PUBLISHED FOR OPPOSITION
Oct 23, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 3, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 18, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 12, 2018 DOCK D ASSIGNED TO EXAMINER
May 29, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Drug delivery agents in the form of powders, liquids, creams, gels, and pastes that facilitate the delivery of therapeutic agents and pharmaceutical preparations; Drug delivery agents in the form of powders, liquids, creams, gels, and pastes that provide controlled release of the active ingredients for a wide variety of therapeutics and pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of therapeutics and pharmaceuticals; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based powders, liquids, creams, gels, and/or pastes for the continuous release of a wide variety of therapeutic and pharmaceutical agents
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005